Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.703
+0.005 (0.69%)
At close: Jan 22, 2025, 4:00 PM
0.738
+0.035 (4.99%)
After-hours: Jan 22, 2025, 6:29 PM EST
Ovid Therapeutics Stock Forecast
OVID's stock price has decreased by -77.61% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Ovid Therapeutics stock have an average target of 4.04, with a low estimate of 1.20 and a high estimate of 8.00. The average target predicts an increase of 474.68% from the current stock price of 0.70.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 4, 2024.
Analyst Ratings
The average analyst rating for OVID stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +326.74% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +326.74% | Sep 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +326.74% | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +326.74% | Jul 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +326.74% | Jul 2, 2024 |
Financial Forecast
Revenue This Year
672.57K
from 391.70K
Increased by 71.71%
Revenue Next Year
5.66M
from 672.57K
Increased by 741.55%
EPS This Year
-0.41
from -0.74
EPS Next Year
-0.31
from -0.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.3M | 28.0M | 92.9M | |||
| Avg | 672,568 | 5.7M | 27.1M | |||
| Low | 480,200 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 221.7% | 4,059.0% | 1,541.8% | |||
| Avg | 71.7% | 741.6% | 379.5% | |||
| Low | 22.6% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.41 | 1.47 | 0.45 | |||
| Avg | -0.41 | -0.31 | -0.57 | |||
| Low | -0.42 | -0.71 | -1.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.